Galliprant and gabapentin are not the same medication. They belong to completely different drug classes, work through different mechanisms in the body, and treat different types of pain in dogs. Veterinarians sometimes prescribe them for overlapping conditions like osteoarthritis, which is likely why the two get confused, but they are distinct drugs that do very different things.
How Galliprant Works
Galliprant (the brand name for grapiprant) is a newer type of anti-inflammatory pain reliever designed specifically for dogs with osteoarthritis. It belongs to a drug class called piprants, which are prostaglandin receptor antagonists. In plain terms, your dog’s body produces a chemical called PGE2 at sites of inflammation. PGE2 binds to several receptors, but one in particular, the EP4 receptor, is the main driver of the pain and inflammation tied to arthritis. Galliprant blocks that specific receptor, stopping the pain signal without interfering with the broader activity of PGE2 elsewhere in the body.
This targeted approach is what sets Galliprant apart from traditional NSAIDs like carprofen or meloxicam, which suppress the entire inflammatory cascade more broadly. By narrowing its focus to just the EP4 receptor, Galliprant aims to reduce some of the gastrointestinal and kidney side effects that older anti-inflammatory drugs can cause.
How Gabapentin Works
Gabapentin is a nerve pain medication originally developed for humans with epilepsy and later adopted widely in veterinary medicine. Rather than targeting inflammation, gabapentin works in the nervous system itself. It reduces the excitability of nerve cells, dampening pain signals before they reach the brain. This makes it particularly useful for neuropathic pain, the kind caused by nerve damage or dysfunction rather than swollen, inflamed joints.
Veterinarians prescribe gabapentin for conditions like nerve-related back pain, spinal cord disorders, and chronic pain that hasn’t responded well to anti-inflammatory drugs alone. It’s also commonly used as a mild sedative before stressful vet visits or procedures. Unlike Galliprant, gabapentin is not FDA-approved specifically for dogs. It’s used off-label, meaning vets rely on clinical experience and published studies to guide dosing.
What Each One Treats
Galliprant is FDA-approved for one specific use: controlling pain and inflammation from osteoarthritis in dogs. It’s given once daily, at a dose of 2 mg/kg, and is designed for long-term management of joint disease.
Gabapentin covers a broader, more varied list of uses. Vets prescribe it for neuropathic pain, post-surgical discomfort, anxiety before veterinary visits, and as part of a multimodal pain plan for arthritis. For neuropathic pain in dogs, dosing typically starts at 5 to 15 mg/kg given twice daily, with the option to increase gradually. For osteoarthritis specifically, gabapentin is sometimes added alongside an anti-inflammatory rather than used as a standalone treatment. It needs to be given two or three times per day, compared to Galliprant’s once-daily dosing.
Side Effects Compared
The side effect profiles reflect how differently these drugs work. Galliprant’s most common issue is gastrointestinal upset. In a clinical trial of 141 dogs, 24 experienced vomiting and 17 had diarrhea or soft stool over a 28-day period. Decreased appetite, lethargy, and in rare cases bloody or mucoid stool were also reported. Because it’s an anti-inflammatory, vets typically monitor bloodwork periodically to check protein levels and organ function.
Gabapentin’s signature side effect is sedation. In one study of 50 dogs, 46% of owners reported noticeable drowsiness, and 18% observed ataxia, which looks like stumbling, wobbling, or bumping into things. These effects tend to be dose-dependent: dogs receiving higher doses were significantly more likely to appear sedated or uncoordinated. The good news is that most owners (65%) said the sedation didn’t bother them at all, and it often lessens after the first few days as the dog adjusts. Gabapentin does not carry the same gastrointestinal risks as anti-inflammatory medications.
Can They Be Used Together?
Yes, and in fact this is a common approach. Because Galliprant reduces inflammation at the joint while gabapentin quiets pain signaling in the nervous system, the two can complement each other. Vets often combine them for dogs with moderate to severe osteoarthritis, or for older dogs dealing with both joint pain and nerve-related discomfort. Using two drugs with different mechanisms can sometimes allow lower doses of each, reducing the chance of side effects from either one.
This combination falls under what veterinarians call multimodal pain management, the idea that attacking pain through multiple pathways at once tends to work better than relying on a single drug. If your vet has prescribed both, that’s why.
Key Differences at a Glance
- Drug class: Galliprant is an anti-inflammatory (prostaglandin receptor antagonist). Gabapentin is a nerve pain modifier.
- Primary target: Galliprant blocks inflammation at the EP4 receptor in joints. Gabapentin reduces nerve cell excitability in the nervous system.
- FDA status for dogs: Galliprant is FDA-approved for canine osteoarthritis. Gabapentin is used off-label.
- Dosing frequency: Galliprant is given once daily. Gabapentin is typically given two to three times daily.
- Main side effects: Galliprant causes GI upset (vomiting, diarrhea). Gabapentin causes sedation and unsteadiness.
- Best suited for: Galliprant targets inflammatory joint pain. Gabapentin targets nerve pain, anxiety, and serves as an add-on for complex pain.